英语翻译A.Section II – Who is An Insured is amended to include as an additional insured the person(s) or organization(s) shown in the Schedule,but only with respect to liability for “bodily injury”,”property damage” or “ personal and advertising injury” caused in whole or in part by :1.Your acts or omissions or2.The acts or omissions of those acting on your behalfIn the performance of your ongoing operations for the additional insured(s) at the location (s) designated above.B.With respect to the insurance afforded to these additional insureds,the following additional exclusions apply:1.All work,including materials,parts or equipment furnished in connection with such work,on the project (other than service,maintenance or repairs) to be performed by or on behalf of the additional insured(s) at the location of the covered operations has been completed,or2.That portion of “your work” out of which the injury or damage arises has been put to its intended use by any person or organization other than another contractor or subcontractor engaged in performing operations for a principal as a part of the same project.(P20)Section II – Who is An Insured is amended to include as an additional insured the person(s) or organization(s) shown in the Schedule,but only with respect to liability for “bodily injury”,”property damage” caused.In whole or in part by “”your work” at the location designated and described for that additional insured and included in the “products-completed operations hazard”.(P21)A.For all sums which the insured becomes legally obligated to pay as damages caused by under COVERAGE A (SECTION Ⅰ),and for all medical expenses caused by accidents under COVERAGE C (SECTION Ⅰ),which can be attributed only to ongoing operations at a single designated construction project shown in the Schedule above:1.A separate Designated Construction Project General Aggregate Limit applies to each designated construction project,and that limit is equal to the amount of the General Aggregate Limit shown in the Declarations.2.The Designated Construction Project General Aggregate Limit is the most we will pay for the sum of all damages under COVERAGE A,except damages because of “bodily injury” or ”property damage” included in the “products-completed operations hazard”,and for medical expenses under COVERAGE regardless of the number of:a.insureds.b.Claims made of “suits” brought orc.Persons or organizations making claims or bringing “suits”.3.Any payments made under COVERAGE A for damages or under COVERAGE C for medical expenses shall reduce the Designated Construction Project General Aggregate Limit for that designated construction project.Such payments shall not reduce the General Aggregate Limit shown in the Declarations nor shall they reduce any other Designated Construction Project General Aggregate Limit for any other designated construction project shown in the Schedule above我需要的是真正的高手翻译，不要金山快译随便就贴上来
██幻世萌█诓
A.第二部分—受保者已被修改为附表中写明的包括一名附加外受保人,受保人或机构,但只遵守全部或者部分由以下事项引起的人身伤害、财产损失或是个人及广告伤害的责任：个人行为或过失、基于个人利益的行为或过失、在上述指定地点为额外的受保者执行持续经营行为.B.考虑到付给这些额外受保者的保险,:以下增加的除外责任适用于：(P20) 附加受保人在已完成受保项目所在地进行的,或以自己利益进行的方案上的（除去服务、维持或者维修）所有工作,包括材料、零件或者是相关工作配备的器材；或者是你工作中超出的部分,如发生的伤害或损失已经被除去另外的承包者或承包商之外的个人或组织归入预期用途第二部分—受保者已被修改为附表中写明的包括一名额外受保人,受保人或机构,但是只是关于在你工作的整个或者部分在为附加受保人指定和描述的并且包含在“产品—完工操作风险”中的地点发生的“人身伤害”、“财产损失”引起的责任.A.对于不能归于以上附表中的单一指定建筑工程的持续运作中的情况,受保人法定支付的所有.意外损失费属于保险范围A（第一部分）,意外事故就医费用属于保险范围C.一份单独的指定建筑工程全年上限适用于每个指定的建筑工程.这个限额与声明中的全年上限总额相等.除开由“产品—完成操作风险”中“人身伤害”、“财产损失”造成的损失,以及保险范围内不管受保者人数多少的医疗费用,带来的案件诉讼索赔,以及索赔或引起诉讼的人或机构,指定工程全年上限额是我们在保险范围A将支付的上限.任何属于保险范围A的损失及保险范围C的医疗费会减少指定建筑工程的全年总限额,不会减少声明中的全年上限额或以上附表中的任何指定建筑工程的指定建筑工程全年上限额.
为您推荐：
其他类似问题
A. Section II – Who is An Insured is amended to include as an additional insured the person(s) or organization(s) shown in the Schedule, but only with respect to liability for “bodily injury”, ”proper...
第二部分 - 谁是被保险人修订 包括作为附加被保险人S或组织（s）所示在附表中，但仅限于对“人身伤害”，“财产损害”或“法律责任个人和广告伤害“全部或部分造成的： 1。您的行为或遗漏或 2。这些行为或2。指定工程项目总累计限额是最我们将支付的所有赔偿款项下的覆盖面，除了因为“身体伤害”或“财产损失”，在“产品完成的操作风险”包括损害赔偿，以及用于医疗根据覆盖费用不论数量： <b...
A. Section II – Who is An Insured is amended to include as an additional insured the person(s) or organization(s) shown in the Schedule, but only with respect to liability for “bodily injury”, ”proper...
A：第二部分 - 谁是被保险人修订，包括作为附加被保险人（S）或组织（s）所示在附表中，但仅限于对“人身伤害”，“财产损害”或“法律责任个人和广告伤害“全部或部分造成的： 1。您的行为或遗漏或 2。这些行为或不作为您的名义行事 在你正在进行的操作的附加被保险人在上述指定的位置（s）（s）的性能。 B.与这些方面给予更多的被保险人的保险，以下附加排除适用： <...
扫描下载二维码(window.slotbydup=window.slotbydup || []).push({
id: '2081942',
container: s,
size: '1000,60',
display: 'inlay-fix'请帮忙翻译一段英文的文章·谢谢了·~！_百度知道
请帮忙翻译一段英文的文章·谢谢了·~！
The updated analysis involving 921 patients confirmed the radium-223 survival benefit (median, selectively targets bone metastases with alpha particles, in men with castration-resistant prostate cancer P&lt.2 two-sided P=0;0.), all patients received the best standard of care. In our phase 3, placebo-controlled study. At the interim analysis. In addition, radium-223, NCT% confidence interval [CI], were not eligible to receive, assessed the effect of radium-223 versus placebo on survival:1 ratio.70; 95% CI. We assessed the efficacy and safety of radium-223 as c hazard ratio.gov number. 11, double-blind, to receive six injections of radium-223 (at a dose of 50 kBq per kilogram of body weight intravenously) or matching placebo, 14, in a 2, significantly improved overall survival (median, or declined docetaxel.9 months vs, which involved 809 ALSYMPCA ClinicalTrials, in addition to the best standard of care. (Funded by Algeta and Bayer HealthCare Pharmaceuticals, randomized.3 months, conducted when 314 deaths had occurred, radium-223 improved overall survival. The primary end point was overall survival.58 to 0.83, we randomly assigned 921 patients who had received. 11AbstractRadium-223 dichloride (radium-223); hazard ratio. Radium-223 was associated with low myelosuppression rates and fewer adverse events.88, which was terminated for efficacy at the prespecified interim analysis. The main secondary efficacy end points included time to the first symptomatic skeletal event and various biochemical end points, an alpha emitter.0 months vs, was performed before crossover from placebo to radium-223; one injection was administered every 4 weeks, 0.001), 0, when 528 deaths had occurred.PMID. An updated analysis, as compared with placebo.55 to 0, 14. Assessments of all main secondary efficacy end points also showed a benefit of radium-233 as compared with placebo. In this study, 0.70, 0.002). A prespecified interim analysis
我有更好的答案
abstractradium-223二氯（镭-223），α发射体，选择性地针对骨转移的α粒子。我们评估和安全的镭-223疗效与安慰剂组相比，除了最好的护理标准，与男性的阉割性前列腺癌骨转移。在我们的3期，随机，双盲，安慰剂对照的研究中，我们随机分配921例，没有资格接受或拒绝，多西他赛，以2:1的比例，收到六注射镭-223（剂量为每公斤体重50 KBQ静脉注射）或匹配的安慰剂一注射给药；每4周。此外，所有患者均接受最好的护理标准。主要终点是总生存期。主要的次要疗效，
当528死亡的发生，从安慰剂交叉前进行镭-223。在中期分析，涉及809例患者，镭-223，与安慰剂组相比，显着改善总生存（中位数，14个月和11.2个月；危险比，0.70；95%可信区间[CI]，0.55到0.88；双面P = 0.002）。更新的分析涉及921例患者证...
氯化镭-223（镭-223），α发射体，选择性地针对骨转移的α粒子。我们评估和安全的镭-223疗效与安慰剂组相比，除了最好的护理标准，与男性的阉割性前列腺癌骨转移。在我们的3期，随机，双盲，安慰剂对照的研究中，我们随机分配921例，没有资格接受或拒绝，多西他赛，以2:1的比例，收到六注射镭-223（剂量为每公斤体重50 KBQ静脉注射）或匹配的安慰剂一注射给药；每4周。此外，所有患者均接受最好的护理标准。主要终点是总生存期。主要的次要疗效终点包括第一次有症状的骨骼事件和各种生化终点。一个预先设定的中期分析时，314的死亡发生，评估镭-223与安慰剂对生存的影响。一个更新的分析，当有528名患者死亡，安慰剂与镭-223交叉之前进行。在中期分析，涉及809例患者，镭-223，与安慰剂组相比，显着改善总...
氯化镭-223（镭-223），α发射体，选择性地针对骨转移的α粒子。我们评估和安全的镭-223疗效与安慰剂组相比，除了最好的护理标准，与男性的阉割性前列腺癌骨转移。在我们的3期，随机，双盲，安慰剂对照的研究中，我们随机分配921例，没有资格接受或拒绝，多西他赛，以2:1的比例，收到六注射镭-223（剂量为每公斤体重50 KBQ静脉注射）或匹配的安慰剂一注射给药；每4周。此外，所有患者均接受最好的护理标准。主要终点是总生存期。主要的次要疗效终点包括第一次有症状的骨骼事件和各种生化终点。一个预先设定的中期分析时，314的死亡发生，评估镭-223与安慰剂对生存的影响。一个更新的分析，当有528名患者死亡，安慰剂与镭-223交叉之前进行。在中期分析，涉及809例患者，镭-223，与安慰剂组相比，显着改善总...
α粒子，镭223氯化（镭-223），α发射器，选择性地针对骨转移。我们评估了镭223的疗效和安全性与安慰剂组相比，除了最好的护理标准，男性阉割性前列腺癌和骨转移。在我们的第3阶段，随机，双盲，安慰剂对照研究，我们随机分配921例患者谁收到了，是没有资格获得，或者多西他赛，以2:1的比例下降，收到六个注射镭223 （50 KBQ剂量为每公斤体重静脉注射）或匹配的安慰剂;注射给药，每4周。此外，所有患者获得最佳的护理标准。主要终点是总生存期。主要，次要疗效终点包括第一症状的的骨骼肌事件和各种生化终点。预先指定中期分析，进行时，发生314人死亡，镭223的生存与安慰剂的效果进行评估。最新分析，发生528人死亡时，进行前交叉安慰剂镭223。在中期分析，其中涉及809例患者中，镭223，与安慰剂相比，显着提高...
二氯化镭-223 (镭-223），阿尔法放射器，有选择性地目标是骨转移瘤 α 粒子。我们评估的疗效和安全性的镭-223 与安慰剂，除了照顾，男性阉割抗前列腺癌和骨转移瘤患者的最佳标准。在我们的阶段 3、 随机、 双盲、 安慰剂对照研究中，我们随机分配 921 病人收到了、 有没有资格获得，或拒绝多烯紫杉醇，2:1 的比例，接收的镭-223 六注射 （剂量 50 kBq 每公斤身体的重量静脉滴注) 或匹配的安慰剂 。管理每 4 周注射一次。此外，所有病人都接受护理的最佳水平。主要终点是整体生存。主要的辅助疗效结束点包括症状性骨骼肌的第一个事件和各种生化结束点的时间。预先指定的临时分析，进行 314 死亡已经发生时，评估对生存镭-223 与安慰剂比较的影响。更新的分析，当发生了 528 人死亡，是之前从安慰剂对镭 223 交叉...
α粒子，镭223氯化（镭－223），α发射器，选择性地针对骨转移。我们评估了镭223的疗效和安全性与安慰剂组相比，除了最好的护理标准，男性阉割性前列腺癌和骨转移。在我们的第3阶段，随机，双盲，安慰剂对照研究，我们随机分配921例患者谁收到了，是没有资格获得，或者多西他赛，以2：1的比例下降，收到六个注射镭223?ǎ担啊。耍拢鸭亮课&#57378;抗&#57466;锾逯鼐猜鲎⑸洌┗蚱ヅ涞陌参考粒蛔⑸涓&#57957;&#59392;&#57566;浚粗堋4送猓&#57574;&#58052;谢颊呋竦米罴训幕だ肀曜糽主要终点是总生存期。主要tx次要疗效终点包括第一症状的的骨骼肌事件和各种生化终点。预先指定中期分析，进行时，发生314人死亡，镭223的生存与安慰剂的效果进行评估。最新分析，发生528人死亡时，进行前交叉安慰剂镭223。在中期分析，...
其他类似问题
为您推荐：
英文的相关知识
等待您来回答
下载知道APP
随时随地咨询
出门在外也不愁求帮忙翻译一段话，要英语的谢谢！_百度知道
求帮忙翻译一段话，要英语的谢谢！
中国是世界上最大的发展中国穿鼎扁刮壮钙憋水铂惊家，人口约占世界总人口的22%。在过去相当长的时期里，由于诸多原因，贫困一直困扰着中国。20世纪80年代中期，中国农村绝大多数地区凭借自身的发展优势，经济得到快速增长，但少数地区由于经济，社会，历史，自然等方面的制约，发展相对滞后。中国政府在致力于经济和社会全面发展的进程中，在全国范围内实施了以解决贫困人口温饱问题为主要目标的有计划，有组织的大规模扶贫开发，极大地缓解了贫困现象。
提问者采纳
China is the largest developing country in the world, with a population accounting for 22% of the world’s total. Over a long period of time the country was plagued by poverty for various reasons. In the middle of 1980s most rural areas saw rapid economic development by capitalizing on their distinctive advantages. However, a minority of areas were still beset with slow economic growth due to economic, social, historical and natural reasons. The Chinese government took practical measures to relieve property and spur economic and social development on a nationwide scale, with an aim to help t穿鼎扁刮壮钙憋水铂惊hose inadequately fed and clothed out of poverty. As a result, the country’s poverty was significantly alleviated.
提问者评价
其他类似问题
为您推荐：
其他3条回答
As the most enormous developing country,China roughs takes 22% of the world total population.This country suffers poverty for rather a long period due to certain reasons.Back in the ;s, a number of regions in rural area took adventage and make the most of their inner strength and prompted on the contrary,to a certain extend,some poverty parts still suffers as a result of the restraint in terms of its economical,societal,historical and natural cources.Hence,the Chinese government conducted a big scale project aiming to resolve the subsistence issues nation wide,striving to purpuit to greatly eliminate the porverty with a well-or...
Chinese is the world&#039;s largest developing country, has a population of about 22% of the total world population. Quite a long time in the past, because of many reasons, poverty has been plagued by China. In twentieth Century 80 time metaphase, China the overwhelming majority of the rural areas with their own development advantages, the rapid economic growth, but a few areas because of the economic, social, historical, natural and other aspects of the constraints, development relative lag. China government committed to economic and social development process, in the nationwide implementation of the solution to the problem of food and clothing for the imp...
China is the world&#039;s largest developing country, the population accounts for about 22% of the world&#039;s population. In quite long period in the past, due to many reasons, and poverty are still with China. In the mid - 1980 - s, the vast majority of rural areas of China with its own advantages, the development of rapid economic growth, but a few areas because of the economic, social, historical and natural constraints, such as development relative lag. The Chinese government is working on the process of economic and social comprehensive development, implemented across the country to solve the problem of poor food and clothing as the main target of plan, o...
英语的相关知识
等待您来回答
下载知道APP
随时随地咨询
出门在外也不愁